81702419/National Natural Science Foundation of China[Grants and Funding] - Search Results

Year	Number of Results
2018	1
2020	1
2021	2
2023	2
2024	2

1

Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma.

Zhang J, Gu C, Song Q, Zhu M, Xu Y, Xiao M, Zheng W. Zhang J, et al. Cell Biosci. 2020 Oct 31;10(1):127. doi: 10.1186/s13578-020-00488-y. Cell Biosci. 2020. PMID: 33292459 Free PMC article. Review.

2

Placenta mesenchymal stem cell-derived extracellular vesicles alleviate liver fibrosis by inactivating hepatic stellate cells through a miR-378c/SKP2 axis.

Zheng W, Bian S, Qiu S, Bishop CE, Wan M, Xu N, Sun X, Sequeira RC, Atala A, Gu Z, Zhao W. Zheng W, et al. Inflamm Regen. 2023 Oct 5;43(1):47. doi: 10.1186/s41232-023-00297-z. Inflamm Regen. 2023. PMID: 37798761 Free PMC article.

3

Identification of acetyl-CoA carboxylase alpha as a prognostic and targeted candidate for hepatocellular carcinoma.

Shen Y, Wang X, Ni Z, Xu S, Qiu S, Zheng W, Zhang J. Shen Y, et al. Clin Transl Oncol. 2023 Aug;25(8):2499-2513. doi: 10.1007/s12094-023-03137-1. Epub 2023 Mar 28. Clin Transl Oncol. 2023. PMID: 36976490

4

DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.

Zhu M, Wu M, Bian S, Song Q, Xiao M, Huang H, You L, Zhang J, Zhang J, Cheng C, Ni W, Zheng W. Zhu M, et al. Cell Biosci. 2021 Feb 23;11(1):42. doi: 10.1186/s13578-021-00555-y. Cell Biosci. 2021. PMID: 33622397 Free PMC article.

5

Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma.

Qiu H, Jiang B, Chen Y, Lin Z, Zheng W, Cao X. Qiu H, et al. J Appl Genet. 2024 May;65(2):355-366. doi: 10.1007/s13353-024-00836-5. Epub 2024 Feb 12. J Appl Genet. 2024. PMID: 38347289

6

Ubiquitin-specific protease 1 facilitates hepatocellular carcinoma progression by modulating mitochondrial fission and metabolic reprogramming via cyclin-dependent kinase 5 stabilization.

Bian S, Ni W, Zhou L, Tong Y, Dai C, Zhao X, Qiang Y, Gao J, Xiao Y, Liu W, Chen C, Lin S, Gong J, Zhao S, Chen Y, Lin Z, Liu D, Zhao H, Zheng W. Bian S, et al. Cell Death Differ. 2024 Sep;31(9):1202-1218. doi: 10.1038/s41418-024-01342-1. Epub 2024 Jul 15. Cell Death Differ. 2024. PMID: 39009653

7

Biological testing of chitosan-collagen-based porous scaffolds loaded with PLGA/Triamcinolone microspheres for ameliorating endoscopic dissection-related stenosis in oesophagus.

Ni W, Lin S, Bian S, Xiao M, Wang Y, Yang Y, Lu C, Zheng W, Zhou P. Ni W, et al. Cell Prolif. 2021 Mar;54(3):e13004. doi: 10.1111/cpr.13004. Epub 2021 Feb 4. Cell Prolif. 2021. PMID: 33543561 Free PMC article.

8

[Clinical application of high mobility group box nuclear protein 1 subcomponent in the progression of liver cancer].

Dong ZZ, Yao M, Zheng WJ, Yao DF. Dong ZZ, et al. Zhonghua Gan Zang Bing Za Zhi. 2018 Nov 20;26(11):869-872. doi: 10.3760/cma.j.issn.1007-3418.2018.11.014. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 30616326 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year